Levosimendan in early sepsis: when good ideas give poor results.
Daniel
D
De Backer
Hendrik
H
Bracht
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume; D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005440:Fluid Therapy; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D019344:Lactic Acid / Q000097:blood; D008102:Liver Circulation / Q000187:drug effects; D010100:Oxygen / Q000097:blood; D011724:Pyridazines / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D012772:Shock, Septic / Q000188:drug therapy* / Q000503:physiopathology; D000077464:Simendan; D013152:Splanchnic Circulation / Q000187:drug effects*; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D019344:Lactic Acid; D000077464:Simendan; D010100:Oxygen